| Indicators | Browse All

Rocket One Inc (HOTH)

Healthcare | Biotechnology | Hoboken, United States |
USD

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 8:20 a.m. UTC

The stock is currently trapped in a severe multi-year downtrend, having lost nearly 99% of its value over the last six years despite a recent annual rebound. While the company recently pivoted from biotechnology to a space-tech and AI chip strategy, triggering a massive retail rally and a 70% surge after hours, the underlying financial reality remains dire. The business is burning cash aggressively, with operating and free cash flows both deeply negative, and it reports significant losses per share. The balance sheet shows minimal debt relative to equity, which is a positive, but the lack of profitability and the massive capital burn rate suggest the new strategy has not yet generated sustainable revenue or profits. Furthermore, the statistical forecasting model predicts a further decline over the next 45 days, indicating that the recent price spike may be a temporary liquidity event rather than a reversal of the long-term trend. Without proof that the new space/AI strategy can generate positive cash flow quickly, the investment case remains speculative and weak.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_84_105 ✓0.401783
MSTL_1050.437837
AutoETS0.456365
MSTL0.464528
MSTL_840.477662
AutoTheta0.508740
AutoARIMA0.560273

Forecast horizon: 60 days | Selected: MSTL_84_105

Forecast Reliability
Score 36%
H-stat 5.47
Ljung-Box p 0.000
Jarque-Bera p 0.601
Excess Kurtosis -0.35
Attribute Value
Sector Healthcare
Debt to Equity Ratio 0.092
Market Cap 26,013,596
Forward P/E -1.92
Beta 0.58
Website https://hoththerapeutics.com

Info Dump

Attribute Value
52 Week Change 0.7685951
Address1 720 Monroe Street
Address2 Suite E514
All Time High 347.0
All Time Low 0.4894
Ask 1.47
Ask Size 200
Average Daily Volume10 Day 38,430,177
Average Volume 8,119,849
Average Volume10Days 38,430,177
Beta 0.576
Bid 1.36
Bid Size 200
Book Value 0.396
City Hoboken
Compensation As Of Epoch Date 1,767,139,200
Country United States
Currency USD
Current Price 1.36
Current Ratio 4.724
Date Short Interest 1,777,507,200
Day High 1.36
Day Low 1.36
Debt To Equity 0.092
Ebitda Margins 0.0
Enterprise Value 4,049,304
Exchange NCM
Exchange Timezone Name UTC
Fifty Day Average 0.80349
Fifty Two Week High 2.45
Fifty Two Week Low 0.4894
Financial Currency USD
First Trade Date Epoch Utc 1,783,690,200
Float Shares 15,787,156
Forward Eps -0.71
Forward P E -1.915493
Free Cashflow -5,543,313
Full Time Employees 2
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Held Percent Insiders 0.02894
Held Percent Institutions 0.041139998
Implied Shares Outstanding 19,127,643
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Last Fiscal Year End 1,767,139,200
Last Split Date 1,666,742,400
Last Split Factor 1:25
Long Business Summary Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
Long Name Rocket One Inc
Market Cap 26,013,596
Max Age 86,400
Message Board Id finmb_434856528
Most Recent Quarter 1,767,139,200
Net Income To Common -12,469,302
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 20,036,519
Open 0.8685
Operating Cashflow -9,803,918
Operating Margins 0.0
Payout Ratio 0.0
Phone 866 239 7459
Previous Close 1.36
Price Hint 4
Price To Book 3.4343436
Profit Margins 0.0
Quick Ratio 4.301
Quote Type EQUITY
Recommendation Key none
Regular Market Day High 1.36
Regular Market Day Low 1.36
Regular Market Open 0.8685
Regular Market Previous Close 1.36
Regular Market Volume 135,373,627
Return On Assets -1.00885
Return On Equity -1.91399
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 19,127,643
Shares Percent Shares Out 0.0417
Shares Short 797,306
Shares Short Previous Month Date 1,774,915,200
Shares Short Prior Month 749,807
Short Name Hoth Therapeutics, Inc.
Short Percent Of Float 0.0429
Short Ratio 0.13
State NJ
Symbol HOTH
Time Zone Full Name America/New_York
Time Zone Short Name EDT
Total Cash 6,247,467
Total Cash Per Share 0.384
Total Debt 5,678
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.8
Trailing Peg Ratio None
Two Hundred Day Average 1.1099426
Underlying Symbol HOTH
Uuid ff6dafe1-fa0d-3a83-9121-424872ea93bf
Volume 135,373,627
Website https://hoththerapeutics.com
Zip 7,030